The global nicotine transdermal patches market is anticipated to grow at a considerable CAGR during the forecast period (2022-2028). A nicotine patch is a medicine that helps people to quit smoking by slowly releasing small amounts of nicotine to curb cravings. They act as a replacement for cigarettes, cigars, and other nicotine-containing products. The major factor driving the demand for the global nicotine transdermal patches market during the forecast period is the increasing research and development coupled with the rising awareness regarding smoking health issues among the population across the globe.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/nicotine-transdermal-patches-market
Moreover, the market is also growing due to the rising awareness regarding the benefits of using nicotine patches. Furthermore, the rising government initiatives and activities to reduce smoking is driving the growth of the market. For instance, in July 2020, WHO together with the UN Interagency Task Force on Non-communicable Diseases, PATH, and the Coalition for Access to NCD Medicines and Products announced a new Access Initiative for Quitting Tobacco. It aims to help the 1.3 billion tobacco users globally to quit by providing free access to nicotine replacement therapy and to Florence, a digital health worker, based on artificial intelligence that dispels myths around COVID-19 and tobacco and helps people develop a personalized plan to quit tobacco.
Browse the full report description “Global Nicotine Transdermal Patches Market Size, Share & Trends Analysis Report, By Type (21mg/patch, 14mg/patch, and 7mg/patch), By Application (Age below 30, Age 30-50, Age above 50), Forecast (2022-2028)” at https://www.omrglobal.com/industry-reports/nicotine-transdermal-patches-market
Some of the key players in the market include Cigna Corp., Dr Reddy’s Laboratories Ltd., GlaxoSmithKline PLC, Johnson & Johnson Services, Inc., and Novartis International AG, among others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in January 2021, Johnson & Johnson announced that it has donated nicotine replacement therapy worth $ 800,000 through its partnership with the Access Initiative for Quitting Tobacco (AIQT) to the Ministry of Health of Jordan. The donation was aimed to support thousands of Jordanians and refugees quit smoking during the COVID-19 pandemic and after.
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
Segment Covered-
- By Type
- By Application
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape- Cigna Corp., Dr Reddy’s Laboratories Ltd., GlaxoSmithKline PLC, Johnson & Johnson Services, Inc., Novartis International AG, and others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Nicotine Transdermal Patches Market Report Segment
By Type
- 21mg/patch
- 14mg/patch
- 7mg/patch
By Application
- Age Below 30
- Age 30-50
- Age Above 50
A full report of Nicotine Transdermal Patches Market is available at: https://www.omrglobal.com/industry-reports/nicotine-transdermal-patches-market
Nicotine Transdermal Patches Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Aveva Group PLC
- Cipla Health Ltd.
- Luye Pharma Group
- Mylan NV (Viatris)
- Perrigo Company PLC
- Revolymer PLC
- Rusan Healthcare Pvt Ltd.
- The Harvard Drug Group LLC
- Teva Pharmaceutical Industries Ltd
- 3M Company
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
